Literature DB >> 17451630

Inhibitory deficits for negative information in persons with major depressive disorder.

Mark A Lau1, Bruce K Christensen, Lance L Hawley, Michael S Gemar, Zindel V Segal.   

Abstract

BACKGROUND: Within Beck's cognitive model of depression, little is known about the mechanism(s) by which activated self-schemas result in the production of negative thoughts. Recent research has demonstrated that inhibitory dysfunction is present in depression, and this deficit is likely valence-specific. However, whether valence-specific inhibitory deficits are associated with increased negative cognition and whether such deficits are specific to depression per se remains unexamined. The authors posit the theory that inhibitory dysfunction may influence the degree to which activated self-schemas result in the production of depressive cognition.
METHOD: Individuals with major depressive disorder (MDD, n=43) versus healthy (n=36) and non-depressed anxious (n=32) controls were assessed on the Prose Distraction Task (PDT), a measure of cognitive inhibition, and the Stop-Signal Task (SST), a measure of motor response inhibition. These two tasks were modified in order to present emotionally valenced semantic stimuli (i.e. negative, neutral, positive).
RESULTS: Participants with MDD demonstrated performance impairments on the PDT, which were most pronounced for negatively valenced adjectives, relative to both control groups. Moreover, these impairments correlated with self-report measures of negative thinking and rumination. Conversely, the performance of the MDD participants did not differ from either control group on the SST.
CONCLUSIONS: Implications of these findings for understanding the mechanisms underlying the development and maintenance of depressive cognition are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17451630     DOI: 10.1017/S0033291707000530

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  14 in total

1.  Relationships of impulsiveness and depressive symptoms in alcohol dependence.

Authors:  Andrzej Jakubczyk; Anna Klimkiewicz; Aleksandra Topolewska-Wochowska; Piotr Serafin; Joanna Sadowska-Mazuryk; Julia Pupek-Pyzioł; Kirk J Brower; Marcin Wojnar
Journal:  J Affect Disord       Date:  2011-10-24       Impact factor: 4.839

Review 2.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 3.  The default mode network and recurrent depression: a neurobiological model of cognitive risk factors.

Authors:  Igor Marchetti; Ernst H W Koster; Edmund J Sonuga-Barke; Rudi De Raedt
Journal:  Neuropsychol Rev       Date:  2012-05-09       Impact factor: 7.444

4.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Authors:  Juan Pablo Lopez; Fabricio Pereira; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Laura M Fiori; Paola Niola; Gustavo Turecki; Fabrice Jollant
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

5.  Patients with borderline personality disorder and major depressive disorder are not distinguishable by their neuropsychological performance: a case-control study.

Authors:  Thomas Beblo; Christoph Mensebach; Katja Wingenfeld; Nina Rullkoetter; Nicole Schlosser; Martin Driessen
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 6.  An attentional scope model of rumination.

Authors:  Anson J Whitmer; Ian H Gotlib
Journal:  Psychol Bull       Date:  2012-12-17       Impact factor: 17.737

7.  Aberrant working memory processing in major depression: evidence from multivoxel pattern classification.

Authors:  Matti Gärtner; M Elisabetta Ghisu; Milan Scheidegger; Luisa Bönke; Yan Fan; Anna Stippl; Ana-Lucia Herrera-Melendez; Sophie Metz; Emilia Winnebeck; Maria Fissler; Anke Henning; Malek Bajbouj; Karsten Borgwardt; Thorsten Barnhofer; Simone Grimm
Journal:  Neuropsychopharmacology       Date:  2018-05-02       Impact factor: 7.853

Review 8.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

9.  Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype?

Authors:  S Morein-Zamir; N A Fineberg; T W Robbins; B J Sahakian
Journal:  Psychol Med       Date:  2009-07-02       Impact factor: 7.723

10.  Rumination in major depressive disorder is associated with impaired neural activation during conflict monitoring.

Authors:  Brandon L Alderman; Ryan L Olson; Marsha E Bates; Edward A Selby; Jennifer F Buckman; Christopher J Brush; Emily A Panza; Amy Kranzler; David Eddie; Tracey J Shors
Journal:  Front Hum Neurosci       Date:  2015-05-12       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.